Products | Respiratory - GSK US Medical Affairs
Find GSK US respiratory product information: Prescribing Information, storage and handling, and more.
Products A-Z - GSK
Below you can find a full list of our products. Our vaccines and medicines are approved in individual countries for specific uses and the information we provide is governed by local regulation. Patients should always ask a healthcare professional for advice.
Products - GSK US
General medicines include our inhaled medicines for asthma and COPD, antibiotics and medicines for skin diseases, in a portfolio which includes pre-launch R&D assets, growth and established products.
Products | Respiratory Overview - GSKpro
Please find a list of our respiratory products below. These medicinal products are subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.
GSK announces cap of $35 per month on U.S. patient out-of …
GSK today announced it will cap out-of-pocket costs for eligible patients at no more than $35 per month for all of its asthma and chronic obstructive pulmonary disease (COPD) medicines,* the most prescribed portfolio of inhalers in the U.S. GSK is taking this action as part of its longstanding commitment to improving access to respiratory ...
GSK Products | GSKPro for Healthcare Professionals
Explore the list of the GSK products available for use, view prescribing information, and access detailed Healthcare Professional websites.
Ellipta-inhaler | Respiratory - GSKpro
Ellipta inhaler information for Healthcare Professionals registered in Ireland.
Respiratory - GSK US
With over 50 years in respiratory care, GSK is committed to helping patients breathe better by continuously redefining treatment for COPD and asthma. We are driven by our commitment to research and uniting innovative science and technology to help people with these respiratory conditions live more comfortably.
Product list | GSK AU
Below you can find the full A-Z list of our products available in Australia. To access the Australian Product Information (PI) and Australian Consumer Medicine Information (CMI), click on the product link below. If you are a healthcare professional, you can access additional information on our products from the GSKPro website.
Ellipta Device | GSK Ireland | Public Site
The Ellipta is a multi-dose dry powder inhaler (DPI). Four different medicines for asthma and/or COPD are available using the Ellipta device. The inhaler is packaged within a moisture-protective foil tray with a desiccant and a peelable lid.